Working... Menu
Trial record 1 of 2 for:    regenxbio | MPS I
Previous Study | Return to List | Next Study

RGX-111 Gene Therapy in Patients With MPS I

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03580083
Recruitment Status : Recruiting
First Posted : July 9, 2018
Last Update Posted : April 17, 2019
Information provided by (Responsible Party):
Regenxbio Inc.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 2020
  Estimated Study Completion Date : January 2022